Conduit Pharmaceuticals logo

Conduit Pharmaceuticals Share Price Today

(NASDAQ: CDT)

Conduit Pharmaceuticals share price is $1.07 & ₹93.16 as on 6 Mar 2025, 2.30 'hrs' IST

$1.07

-0.06

(-5.31%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Conduit Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Conduit Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Conduit Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Conduit Pharmaceuticals share price movements

  • Today's Low: $0.99
    Today's High: $1.10

    Day's Volatility :10.0%

  • 52 Weeks Low: $0.98
    52 Weeks High: $392.00

    52 Weeks Volatility :99.75%

Conduit Pharmaceuticals (CDT) Returns

PeriodConduit Pharmaceuticals IncIndex (Russel 2000)
3 Months
-88.7%
0.0%
6 Months
-91.41%
0.0%
1 Year
-99.61%
0.0%
3 Years
-99.9%
-11.6%

Conduit Pharmaceuticals (CDT) Key Statistics

in dollars & INR

Previous Close
$1.13
Open
$1.1
Today's High
$1.1
Today's Low
$0.989999
Market Capitalization
$5.3M
Today's Volume
$1.6M
52 Week High
$392.0
52 Week Low
$0.98
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-22.21
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Conduit Pharmaceuticals Stock (CDT) from India?

It is very easy for Indian residents to invest directly in Conduit Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Conduit Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Conduit Pharmaceuticals or CDT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Conduit Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Conduit Pharmaceuticals shares which would translate to 0.814 fractional shares of Conduit Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Conduit Pharmaceuticals, in just a few clicks!

Returns in Conduit Pharmaceuticals (CDT) for Indian investors in Rupees

The Conduit Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Conduit Pharmaceuticals investment value today

Current value as on today

₹5,454

Returns

₹94,546

(-94.55%)

Returns from Conduit Pharmaceuticals Stock

₹99,611 (-99.61%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Conduit Pharmaceuticals (CDT)

-8.16%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Conduit Pharmaceuticals Shares from India has dropped by -8.16% over the past 30 days, indicating reduced transactional activity.

-7%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Conduit Pharmaceuticals Stock from India on INDmoney has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Conduit Pharmaceuticals

Insights on Conduit Pharmaceuticals Stock (Ticker Symbol: CDT)

  • Price Movement

    In the last 1 month, CDT stock has moved down by -31.0%
  • CDT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 166.1%

Conduit Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Conduit Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Conduit Pharmaceuticals (CDT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Conduit Pharmaceuticals Inc logo
-40.56%
-91.41%
-99.61%
-99.9%
-99.9%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Conduit Pharmaceuticals Inc logo
NA
NA
NA
0.0
0.0
-1.09
NA
-9.5
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Conduit Pharmaceuticals Inc logo
NA
$5.3M
-99.9%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
Organization
Conduit Pharmaceuticals
Employees
7
CEO
Dr. David Joszef Tapolczay
Industry
Miscellaneous

Management People of Conduit Pharmaceuticals

NameTitle
Dr. David Joszef Tapolczay
CEO & Director
Mr. James Bligh
Interim CFO & Director
Dr. Joanne M. Holland
Chief Scientific Officer

Important FAQs about investing in CDT Stock from India :

What is Conduit Pharmaceuticals share price today?

Conduit Pharmaceuticals share price today stands at $1.07, Open: $1.10 ; Previous Close: $1.13 ; High: $1.10 ; Low: $0.99 ; 52 Week High: $392.00 ; 52 Week Low: $0.98.

The stock opens at $1.10, after a previous close of $1.13. The stock reached a daily high of $1.10 and a low of $0.99, with a 52-week high of $392.00 and a 52-week low of $0.98.

Can Indians buy Conduit Pharmaceuticals shares?

Yes, Indians can invest in the Conduit Pharmaceuticals (CDT) from India.

With INDmoney, you can buy Conduit Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Conduit Pharmaceuticals at zero transaction cost.

How can I buy Conduit Pharmaceuticals shares from India?

It is very easy to buy Conduit Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Conduit Pharmaceuticals (CDT) be purchased?

Yes, you can buy fractional shares of Conduit Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Conduit Pharmaceuticals stocks?

To start investing in Conduit Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Conduit Pharmaceuticals Stock (CDT)?

Today’s highest price of Conduit Pharmaceuticals (CDT) is $1.10.

Today’s lowest price of Conduit Pharmaceuticals (CDT) is $0.99.

What is today's market capitalisation of Conduit Pharmaceuticals?

Today's market capitalisation of Conduit Pharmaceuticals CDT is 5.3M

What is the 52 Week High and Low Range of Conduit Pharmaceuticals Stock (CDT)?

  • 52 Week High

    $392.00

  • 52 Week Low

    $0.98

What are the historical returns of Conduit Pharmaceuticals (CDT)?

  • 1 Month Returns

    -40.56%

  • 3 Months Returns

    -91.41%

  • 1 Year Returns

    -99.61%

  • 5 Years Returns

    -99.9%

Who is the Chief Executive Officer (CEO) of Conduit Pharmaceuticals ?

Dr. David Joszef Tapolczay is the current Chief Executive Officer (CEO) of Conduit Pharmaceuticals.